Biomerica (BMRA) Change in Cash (2010 - 2026)

Biomerica has disclosed Change in Cash across 17 years of filings, most recently posting -$1.2 million for Q1 2026.

• Change in Cash for Q1 2026 came in at -$1.2 million, down 275.95% year-over-year; the trailing twelve-month figure through Feb 2026 was -$1.7 million (up 23.88% YoY), and the FY2025 annual result was -$1.8 million, up 68.1% from the prior year.
• Change in Cash came in at -$1.2 million for Q1 2026 at Biomerica, down from -$510000.0 in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $6.4 million in Q2 2023 to a low of -$4.3 million in Q2 2022.
• The 5-year median for Change in Cash is -$854000.0 (2023), against an average of -$344756.0.
• Across the five-year window, Change in Cash surged 823.37% in 2022 and sank 1195.57% in 2023, its largest moves.
• Biomerica's Change in Cash stood at -$1.0 million in 2022, then advanced by 15.28% to -$854000.0 in 2023, then surged by 47.54% to -$448000.0 in 2024, then decreased by 13.84% to -$510000.0 in 2025, then tumbled by 136.67% to -$1.2 million in 2026.
• The last three Change in Cash figures came in at -$1.2 million (Q1 2026), -$510000.0 (Q4 2025), and $654000.0 (Q3 2025), per Business Quant data.